Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Neuronal Pathway
100%
Neurodegeneration
100%
Rapid Progression
100%
Multiple Sclerosis Disability
100%
Relapsing-remitting multiple Sclerosis
100%
Multiple Sclerosis Treatment
75%
Hazard Ratio
50%
Multiple Sclerosis
50%
Expanded Disability Status Scale
50%
Disability Progression
50%
Moderate Disability
50%
Northern European
50%
Israel
25%
Odds Ratio
25%
Tel Aviv
25%
Disability
25%
Disease Duration
25%
Molecular Pathways
25%
Gene Expression
25%
Jewish Patients
25%
Age of Onset
25%
SHEBA
25%
Environmental Influence
25%
Walking Aids
25%
Genetic Influences
25%
Iraq
25%
Severe Disabilities
25%
Gene Expression Analysis
25%
Neurite
25%
Northern Europe
25%
Differentially Expressed Genes
25%
Geographic Distribution
25%
Genetic Components
25%
Peripheral Blood
25%
Axon Branching
25%
Enhanced Process
25%
Myelin Sheath
25%
Risk of Progression
25%
Environmental Components
25%
Age at Treatment
25%
Microarray Gene Expression Analysis
25%
Neocortical Neurons
25%
Immunomodulatory Drugs (IMiDs)
25%
Neuroscience
Neurodegeneration
100%
Multiple Sclerosis
100%
Relapsing Remitting Multiple Sclerosis
100%
Neuronal Pathway
100%
Gene Expression
75%
Expression Analysis
50%
Expanded Disability Status Scale
50%
Genetics
50%
Neurite
25%
Neurite Outgrowth
25%
Myelin
25%